HealthStream (NASDAQ:HSTM) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

HealthStream, Inc. (NASDAQ:HSTM)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $22.48 and traded as high as $26.31. HealthStream shares last traded at $25.70, with a volume of 181,073 shares changing hands.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on HSTM. Canaccord Genuity Group raised their target price on shares of HealthStream to $24.00 and gave the stock a “hold” rating in a research report on Wednesday, May 6th. Wall Street Zen upgraded HealthStream from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Weiss Ratings raised HealthStream from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, HealthStream has an average rating of “Hold” and a consensus target price of $24.00.

HealthStream Trading Down 1.6%

The business has a 50 day simple moving average of $23.90 and a 200-day simple moving average of $22.48. The stock has a market capitalization of $750.95 million, a price-to-earnings ratio of 38.36, a price-to-earnings-growth ratio of 2.96 and a beta of 0.47.

HealthStream (NASDAQ:HSTM) last posted its quarterly earnings results on Monday, May 4th. The technology company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. HealthStream had a return on equity of 6.47% and a net margin of 6.39%.The company had revenue of $81.20 million during the quarter, compared to analysts’ expectations of $79.68 million. Research analysts predict that HealthStream, Inc. will post 0.74 EPS for the current year.

HealthStream Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Monday, May 18th were issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Monday, May 18th. HealthStream’s payout ratio is presently 20.90%.

HealthStream announced that its board has initiated a share repurchase plan on Friday, March 13th that authorizes the company to repurchase $10.00 million in shares. This repurchase authorization authorizes the technology company to repurchase up to 1.7% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board believes its shares are undervalued.

Insider Activity at HealthStream

In related news, EVP Kevin P. O’hara sold 3,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 20th. The shares were sold at an average price of $24.08, for a total transaction of $72,240.00. Following the completion of the transaction, the executive vice president owned 20,982 shares of the company’s stock, valued at approximately $505,246.56. This represents a 12.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Linda Rebrovick sold 2,000 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $25.00, for a total transaction of $50,000.00. Following the transaction, the director directly owned 54,181 shares in the company, valued at approximately $1,354,525. This represents a 3.56% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 20.40% of the company’s stock.

Institutional Trading of HealthStream

A number of institutional investors and hedge funds have recently made changes to their positions in HSTM. Royal Bank of Canada boosted its holdings in HealthStream by 194.2% in the first quarter. Royal Bank of Canada now owns 43,899 shares of the technology company’s stock valued at $1,413,000 after acquiring an additional 28,977 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in HealthStream by 15.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 54,354 shares of the technology company’s stock valued at $1,749,000 after acquiring an additional 7,211 shares during the period. Jane Street Group LLC acquired a new stake in HealthStream during the first quarter worth about $1,532,000. JPMorgan Chase & Co. increased its stake in HealthStream by 302.0% during the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock worth $6,860,000 after acquiring an additional 186,231 shares during the last quarter. Finally, American Century Companies Inc. increased its stake in HealthStream by 11.6% during the second quarter. American Century Companies Inc. now owns 58,541 shares of the technology company’s stock worth $1,620,000 after acquiring an additional 6,096 shares during the last quarter. 69.58% of the stock is currently owned by institutional investors and hedge funds.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.